Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053567
Filing Date
2020-11-12
Accepted
2020-11-12 16:12:58
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20200930.htm 10-Q 2139834
2 EX-10.1 achv-ex101_273.htm EX-10.1 14204
3 EX-10.2 achv-ex102_272.htm EX-10.2 15759
4 EX-10.3 achv-ex103_270.htm EX-10.3 86492
5 EX-10.4 achv-ex104_271.htm EX-10.4 82563
6 EX-31.1 achv-ex311_8.htm EX-31.1 9069
7 EX-31.2 achv-ex312_9.htm EX-31.2 9068
8 EX-32.1 achv-ex321_6.htm EX-32.1 4882
9 EX-32.2 achv-ex322_7.htm EX-32.2 4887
  Complete submission text file 0001564590-20-053567.txt   7317809

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT achv-20200930.xml EX-101.INS 1330684
11 XBRL TAXONOMY EXTENSION SCHEMA achv-20200930.xsd EX-101.SCH 57203
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20200930_cal.xml EX-101.CAL 42109
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20200930_def.xml EX-101.DEF 240859
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20200930_lab.xml EX-101.LAB 432181
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20200930_pre.xml EX-101.PRE 343602
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 201306819
SIC: 2835 In Vitro & In Vivo Diagnostic Substances